None
Quote | iShares Biotechnology ETF (NASDAQ:IBB)
Last: | $136.20 |
---|---|
Change Percent: | -0.16% |
Open: | $135.3 |
Close: | $136.20 |
High: | $136.4225 |
Low: | $134.76 |
Volume: | 792,704 |
Last Trade Date Time: | 07/05/2024 03:00:00 am |
News | iShares Biotechnology ETF (NASDAQ:IBB)
2024-07-05 06:20:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips The healthcare sector continues to be a hotbed of innovation, with biotechnology leading the charge. From groundbreaking gene therapies to next-generation cancer treatments, biotech companies...
2024-07-05 01:42:52 ET Summary Amgen shares have outperformed IBB by over 40% in the past year, driven higher by a major surge post-earnings in May. With a current price-to-earnings multiple in the mid-teens, I assert that solid and consistent EPS growth ahead warrants a higher va...
Message Board Posts | iShares Biotechnology ETF (NASDAQ:IBB)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $IBB News Article - Ishares Biotechnology Etf IBB Trading Signals | whytestocks | investorshangout | 06/17/2022 3:15:58 PM |
$INVVY will Dip and all to $3.00 | Traderprofessional1 | investorshub | 05/19/2020 6:17:38 PM |
#STOCKS #StockMarket #biotech #LABU #StockMarketCrash20 #STOCKSTOBUY #stockmarke | Traderprofessional1 | investorshub | 05/12/2020 4:11:13 PM |
investorshub.advfn.com/uimage/uploads/2019/12/31/vuuouibb_ddee31_6m_1m_li | nowwhat2 | investorshub | 12/31/2019 4:27:06 PM |
Price Target On The NASDAQ BioTech ETF Revealed | ITMS | investorshub | 01/29/2018 7:59:53 PM |
News, Short Squeeze, Breakout and More Instantly...
iShares Biotechnology ETF Company Name:
IBB Stock Symbol:
NASDAQ Market:
2024-06-28 22:58:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-05-28 08:18:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...